FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2140821430> ?p ?o ?g. }

• W2140821430 endingPage "1179" @default.
• W2140821430 startingPage "1170" @default.
• W2140821430 abstract "In vitro studies were conducted to identify the cytochromes P450 (P450s) involved in the formation of 2- and 3-hydroxycarbamazepine, metabolites that may serve as precursors in the formation of protein-reactive metabolites. Human liver microsomes (HLMs) converted carbamazepine (30-300 microM) to 3-hydroxycarbamazepine at rates >25 times those of 2-hydroxycarbamazepine. Both the 2- and 3-hydroxylation of carbamazepine appeared to conform to monophasic Michaelis-Menten kinetics in HLMs (apparent K(m) values, approximately 1640 and approximately 217 microM; apparent V(max) values, approximately 5.71 and approximately 46.9 pmol/mg of protein/min, respectively). Rates of carbamazepine 2- and 3-hydroxylation correlated strongly with CYP2B6 activity (r >or= 0.757) in a panel of HLMs (n = 8). Carbamazepine 3-hydroxylation also correlated significantly with CYP2C8 activity at a carbamazepine concentration of 30 microM. Formation of 2- and 3-hydroxycarbamazepine did not correlate significantly with any other P450 activities. The chemical inhibitors ketoconazole (CYP3A) and 7-EFC (CYP2B6) inhibited both 2- and 3-hydroxycarbamazepine formation whereas 4-methylpyrazole (CYP2E1) markedly decreased 2-hydroxycarbamazepine formation. Several recombinant P450s catalyzed carbamazepine 2- and 3-hydroxylation, but after adjustment for relative hepatic abundance, CYP3A4 and CYP2B6 appeared to be the major catalysts of carbamazepine 3-hydroxylase activity, and at least five P450s were significant contributors to 2-hydroxycarbamazepine formation; CYP2E1 made the greatest contribution to the Cl(int) of carbamazepine 2-hydroxylation (approximately 30%), but P450s CYP1A2, 2A6, 2B6, and 3A4 also made significant contributions (approximately 13-18%). These results suggest that CYP2B6 and CYP3A4 are largely responsible for the formation of 3-hyrdoxycarbamazepine, whereas multiple P450s (CYP1A2, 2A6, 2B6, 2E1, and 3A4) contributed to 2-hydroxycarbamazepine formation." @default.
• W2140821430 created "2016-06-24" @default.
• W2140821430 creator A5001874759 @default.
• W2140821430 creator A5005624600 @default.
• W2140821430 creator A5058532950 @default.
• W2140821430 date "2002-11-01" @default.
• W2140821430 modified "2023-10-17" @default.
• W2140821430 title "Pathways of Carbamazepine Bioactivation in Vitro I. Characterization of Human Cytochromes P450 Responsible for the Formation of 2- and 3-Hydroxylated Metabolites" @default.
• W2140821430 cites W14345246 @default.
• W2140821430 cites W1520746198 @default.
• W2140821430 cites W1965303172 @default.
• W2140821430 cites W1981083430 @default.
• W2140821430 cites W2015661700 @default.
• W2140821430 cites W2018790451 @default.
• W2140821430 cites W2031069334 @default.
• W2140821430 cites W2041939624 @default.
• W2140821430 cites W2042692588 @default.
• W2140821430 cites W2047616109 @default.
• W2140821430 cites W2049474982 @default.
• W2140821430 cites W2061895553 @default.
• W2140821430 cites W2069829480 @default.
• W2140821430 cites W2077037008 @default.
• W2140821430 cites W2079198255 @default.
• W2140821430 cites W2087706351 @default.
• W2140821430 cites W2090402650 @default.
• W2140821430 cites W2018887634 @default.
• W2140821430 doi "https://doi.org/10.1124/dmd.30.11.1170" @default.
• W2140821430 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12386121" @default.
• W2140821430 hasPublicationYear "2002" @default.
• W2140821430 type Work @default.
• W2140821430 sameAs 2140821430 @default.
• W2140821430 citedByCount "109" @default.
• W2140821430 countsByYear W21408214302012 @default.
• W2140821430 countsByYear W21408214302013 @default.
• W2140821430 countsByYear W21408214302014 @default.
• W2140821430 countsByYear W21408214302015 @default.
• W2140821430 countsByYear W21408214302016 @default.
• W2140821430 countsByYear W21408214302017 @default.
• W2140821430 countsByYear W21408214302018 @default.
• W2140821430 countsByYear W21408214302019 @default.
• W2140821430 countsByYear W21408214302020 @default.
• W2140821430 countsByYear W21408214302021 @default.
• W2140821430 countsByYear W21408214302022 @default.
• W2140821430 countsByYear W21408214302023 @default.
• W2140821430 crossrefType "journal-article" @default.
• W2140821430 hasAuthorship W2140821430A5001874759 @default.
• W2140821430 hasAuthorship W2140821430A5005624600 @default.
• W2140821430 hasAuthorship W2140821430A5058532950 @default.
• W2140821430 hasConcept C109650736 @default.
• W2140821430 hasConcept C11824378 @default.
• W2140821430 hasConcept C140027455 @default.
• W2140821430 hasConcept C169760540 @default.
• W2140821430 hasConcept C181199279 @default.
• W2140821430 hasConcept C185592680 @default.
• W2140821430 hasConcept C202751555 @default.
• W2140821430 hasConcept C2777477808 @default.
• W2140821430 hasConcept C2778186239 @default.
• W2140821430 hasConcept C2779253243 @default.
• W2140821430 hasConcept C2781109383 @default.
• W2140821430 hasConcept C50605568 @default.
• W2140821430 hasConcept C526171541 @default.
• W2140821430 hasConcept C55493867 @default.
• W2140821430 hasConcept C62231903 @default.
• W2140821430 hasConcept C86745063 @default.
• W2140821430 hasConcept C86803240 @default.
• W2140821430 hasConcept C87644729 @default.
• W2140821430 hasConcept C98274493 @default.
• W2140821430 hasConceptScore W2140821430C109650736 @default.
• W2140821430 hasConceptScore W2140821430C11824378 @default.
• W2140821430 hasConceptScore W2140821430C140027455 @default.
• W2140821430 hasConceptScore W2140821430C169760540 @default.
• W2140821430 hasConceptScore W2140821430C181199279 @default.
• W2140821430 hasConceptScore W2140821430C185592680 @default.
• W2140821430 hasConceptScore W2140821430C202751555 @default.
• W2140821430 hasConceptScore W2140821430C2777477808 @default.
• W2140821430 hasConceptScore W2140821430C2778186239 @default.
• W2140821430 hasConceptScore W2140821430C2779253243 @default.
• W2140821430 hasConceptScore W2140821430C2781109383 @default.
• W2140821430 hasConceptScore W2140821430C50605568 @default.
• W2140821430 hasConceptScore W2140821430C526171541 @default.
• W2140821430 hasConceptScore W2140821430C55493867 @default.
• W2140821430 hasConceptScore W2140821430C62231903 @default.
• W2140821430 hasConceptScore W2140821430C86745063 @default.
• W2140821430 hasConceptScore W2140821430C86803240 @default.
• W2140821430 hasConceptScore W2140821430C87644729 @default.
• W2140821430 hasConceptScore W2140821430C98274493 @default.
• W2140821430 hasIssue "11" @default.
• W2140821430 hasLocation W21408214301 @default.
• W2140821430 hasLocation W21408214302 @default.
• W2140821430 hasOpenAccess W2140821430 @default.
• W2140821430 hasPrimaryLocation W21408214301 @default.
• W2140821430 hasRelatedWork W1998541081 @default.
• W2140821430 hasRelatedWork W2028921444 @default.
• W2140821430 hasRelatedWork W2033644570 @default.
• W2140821430 hasRelatedWork W2035465414 @default.
• W2140821430 hasRelatedWork W2112546684 @default.
• W2140821430 hasRelatedWork W2277368739 @default.
• W2140821430 hasRelatedWork W2369534447 @default.

• next